Sympathetic hyperactivity and cardiac dysfunction post-MI: Different impact of specific CNS versus general AT1 receptor blockade

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 4, 2007, Pages 479-486

  Huang, Bing S ^a   Ahmad, Monir ^a   Tan, Junhui ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Angiotensin; Autonomic nervous system; Brain; Heart failure; Hemodynamics

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOSARTAN; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; AUTORADIOGRAPHY; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FIBROSIS; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEMODYNAMICS; NONHUMAN; NORADRENALIN RELEASE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SYMPATHETIC TONE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CENTRAL NERVOUS SYSTEM; DRUG ADMINISTRATION ROUTES; HEART; HEMODYNAMICS; KIDNEY; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

RATTUS; RATTUS NORVEGICUS;

EID: 34548858420     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.07.047     Document Type: Article

References (24)

1. Wang H., Huang B.S., Ganten D., and Leenen F.H.H. Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ. Res. 94 (2004) 843-849
2. Lal A., Veinot J.P., and Leenen F.H.H. Critical role of CNS effects of aldosterone in cardiac remodeling post myocardial infarction in rats. Cardiovasc. Res. 64 (2004) 437-447
3. Zhang Z.H., Francis J., Weiss R.M., and Felder R.B. The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am. J. Physiol. 283 (2002) H423-H433
4. 1 receptor and ACE densities after myocardial infarct in rats. Am. J. Physiol. 286 (2004) H1665-H1671
5. Zhang W., Huang B.S., and Leenen F.H.H. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am. J. Physiol. 276 (1999) H1608-H1616
6. Leenen F.H.H., Yuan B., and Huang B.S. Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am. J. Physiol. 277 (1999) H1786-H1792
7. + channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am. J. Physiol. 288 (2005) H2491-H2497
8. Tan J., Wang H., and Leenen F.H.H. Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats. Am. J. Physiol. 286 (2004) H1665-H1671
9. Huang B.S., Cheung W.J., Wang H., Tan J., White R.A., and Leenen F.H.H. Activation of brain renin-angiotensin-aldosterone system by central sodium in Wistar rats. Am. J. Physiol. 291 (2006) H1109-H1117
10. Lal A., Veinot J.P., Ganten D., and Leenen F.H.H. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J. Mol. Cell Cardiol. 39 (2005) 521-529
11. Pourdjabbar A., Parker T.G., Nguyen Q.T., Desjardins J.F., Lapointe N., Tsoporis J.N., et al. Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling. Am. J. Physiol. 288 (2005) H1997-H2005
12. + exchanger and LV dysfunction after myocardial infarction in rats. Am. J. Physiol. 277 (1999) H610-H616
13. Martinez L.A., and Villalobos-Molina R. Early and chronic captopril or losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats. Arch. Med. Res. 34 (2003) 357-361
14. Wang J.M., Tan J., and Leenen F.H.H. Central nervous system blockade by peripheral administration of AT1 receptor blockers. J. Cardiovasc. Pharmacol. 41 (2003) 593-599
15. DiBona G.F., and Sawin L.L. Renal nerve activity in conscious rats during volume expansion and depletion. Am. J. Physiol. 248 (1985) F15-F23
16. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Acadamic Press, San Diego, CA
17. Francis J., Weiss R.M., Wei S.G., Johnson A.K., Beltz T.G., Zimmerman K., et al. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am. J. Physiol. 281 (2001) H2241-H2251
18. Francis J., Zhang Z.H., Weiss R.M., and Felder R.B. Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am. J. Physiol. 287 (2004) H791-H797
19. 1 receptors. Brain Res. 871 (2000) 29-38
20. Jasmin J.F., Calderone A., Leung T.K., Villeneuve L., and Dupuis J. Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan. Cardiovasc. Res. 58 (2003) 621-631
21. Lacour C., Roccon A., Galindo G., Canals F., Hogie M., Segondy D., et al. Effects of differential blockade of the renin-angiotensin system in postinfarcted rats. Fundam. Clin. Pharmacol. 18 (2004) 299-307
22. Thai H.M., Van H.T., Gaballa M.A., Goldman S., and Raya T.E. Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. Am. J. Physiol. 276 (1999) H873-H880
23. Hoffmann S., Krause T., van Geel P.P., Willenbrock R., Pagel I., Pinto Y.M., et al. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy. J. Mol. Med. 79 (2001) 601-608
24. 1-receptor blockade and sympathetic neurotransmission in cardiovascular disease. Auton. Autacoid. Pharmacol. 23 (2003) 285-296